Showing results (621-630 of 763) with videos related to
Sort By:
Pageof 77
Blood|May 14, 2005
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseasesManfred Rieger, Pier Mannuccio Mannucci, Johanna A Kremer Hovinga, et al.Journal of Hypertension|January 19, 2011
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trialPiero Ruggenenti, Anna Fassi, Aneliya Parvanova Ilieva, et al.Stem Cells and Development|November 10, 2011
Human amniotic fluid stem cell preconditioning improves their regenerative potentialCinzia Rota, Barbara Imberti, Michela Pozzobon, et al.Kidney International|March 1, 2013
The GFR and GFR decline cannot be accurately estimated in type 2 diabeticsFlavio Gaspari, Piero Ruggenenti, Esteban Porrini, et al.Stem Cell Reports|March 11, 2015
Direct reprogramming of human bone marrow stromal cells into functional renal cells using cell-free extractsEvangelia Papadimou, Marina Morigi, Paraskevas Iatropoulos, et al.BMJ Global Health|October 27, 2017
Do attributes of persons with chronic kidney disease differ in low-income and middle-income countries compared with high-income countries? Evidence from population-based data in six countriesShuchi Anand, Yuanchao Zheng, Maria E Montez-Rath, et al.The Lancet. Diabetes & Endocrinology|February 10, 2015
Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trialDick de Zeeuw, Deborah A Anzalone, Valerie A Cain, et al.Journal of the American Society of Nephrology : JASN|March 22, 2014
Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?Maria Chiara Marinozzi, Laura Vergoz, Tania Rybkine, et al.Hypertension (Dallas, Tex. : 1979)|March 17, 2010
Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathyLiffert Vogt, Carlos Chiurchiu, Harbajan Chadha-Boreham, et al.Blood|January 23, 2015
Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndromeElizabeth C Schramm, Lubka T Roumenina, Tania Rybkine, et al.Pageof 77